Cite
Puliyanda DP, Jordan SC, Kim IK, et al. Use of Rituximab for persistent EBV DNAemia, and Its effect on donor-specific antibody development in pediatric renal transplant recipients: A case series. Pediatr Transplant. 2021;25(8):e14113doi: 10.1111/petr.14113.
Puliyanda, D. P., Jordan, S. C., Kim, I. K., Patel, M., Murthy, A., Huang, E., Zhang, X., Reinsmoen, N., Kamil, E. S., & Toyoda, M. (2021). Use of Rituximab for persistent EBV DNAemia, and Its effect on donor-specific antibody development in pediatric renal transplant recipients: A case series. Pediatric transplantation, 25(8), e14113. https://doi.org/10.1111/petr.14113
Puliyanda, Dechu P, et al. "Use of Rituximab for persistent EBV DNAemia, and Its effect on donor-specific antibody development in pediatric renal transplant recipients: A case series." Pediatric transplantation vol. 25,8 (2021): e14113. doi: https://doi.org/10.1111/petr.14113
Puliyanda DP, Jordan SC, Kim IK, Patel M, Murthy A, Huang E, Zhang X, Reinsmoen N, Kamil ES, Toyoda M. Use of Rituximab for persistent EBV DNAemia, and Its effect on donor-specific antibody development in pediatric renal transplant recipients: A case series. Pediatr Transplant. 2021 Dec;25(8):e14113. doi: 10.1111/petr.14113. Epub 2021 Aug 21. PMID: 34418254.
Copy
Download .nbib